陈波博士是海外高层次人才特聘专家, 目前担任华润医药集团首席科学家, 在生物技术和制药行业拥有超过20年的国际职业生涯，包括在美国NIH，AstraZeneca等顶尖科研机构和制药公司从事基础研究和新药研发团队领导者的工作经历，具有从靶点发现到临床开发和商业运作的整个研发价值链的研发背景。他博士毕业于中国人民解放军空军军医大学，在美国NIH完成博士后，其后还获得美国Hood College工商管理硕士学位。他迄今在著名期刊上发表国际学术论文,专著章节和专利共30余篇，包括发表在Annals of the Rheumatic Diseases, Nature  Communication, Nature Immunology, Nature Medicine, PNAS  等顶尖杂志上的论文。并曾获得了卫生部的科技进步二等奖，AstraZeneca的员工白金奖和银奖，NIH的卓越研究员奖，齐鲁制药集团的卓越领导奖等。

Dr. Bo Chen is a specially-appointed expert for overseas high-level talents . He is currently the Chief Scientific Officer at China Resources Pharmaceutical Group Limited.  He has more than 20 years of international career in the biotechnology and pharmaceutical industries, including basic research and innovative drug R&D team leadership in top scientific research institutions and pharmaceutical companies such as the National Institutes of Health, AstraZeneca, etc. He has R&D background in the entire R&D value chain from target discovery to clinical development and commercial operation. He received his PhD. degree from the Air Force Medical University (China), completed the postdoctoral fellowship at the National Institutes of Health in the United States, and later obtained an MBA degree from Hood College (U.S.A). He has published dozens of academic papers, book chapters  and patents in peer-reviewed journals, including papers published in top journals such as Annals of the Rheumatic Diseases, Nature Communication, Nature Immunology, Nature Medicine, PNAS, etc. And has won the second prize of the Ministry of Health's Science and Technology Progress Award, the AstraZeneca Staff Platinum Award and Silver Award, the NIH Outstanding Researcher Award, Qilu Pharmaceutical Group's Outstanding Leadership Award, etc.